bioAffinity strikes federal distribution deal for CyPath Lung test
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/17/2026
- US stock futures rise as oil pullback amplifies Fed rate-hike boost
- Oil prices extend losses as supply disruption fears ease
- JPMorgan Fed scenario analysis: 5 paths for the S&P 500 today
- Exclusive-SK Hynix in talks with Intel about deal to make memory chips in US for the first time, sources say
- Trade the FOMC: How stocks tend to perform on Fed hike days
- Generac strikes $8B supply deal with Amazon for data center power
- Wall St ends lower after Fed hikes interest rates, sees more tightening ahead
- Shipping stocks on fire — but cracks are forming in the rate rally
- JPMorgan Fed scenario analysis: 5 paths for the S&P 500 today
- Turkish Stocks Fall 6%, Triggering Market-wide Circuit Breaker - Bloomberg
bioAffinity Technologies and AvMEDICAL Announce Nationwide Federal Healthcare Distribution Agreement for CyPath® Lung
August 18, 2026 8:00 AM EDTNew partners national sales force will market CyPath Lung to federal healthcare agencies, including VA medical centers nationwide
Agreement significantly expands bioAffinity's commercial reach through AvMEDICAL's existing sales teamÂ
Service-Disabled Veteran-Owned AvMEDICAL provides access to established government procurement channels
SAN ANTONIO--(BUSINESS WIRE)-- bioAffinity Technologies,... More
